Circulating cell-free DNA-based epigenetic assay can detect early breast cancer

BACKGROUND: Circulating cell-free DNA (cfDNA) has recently been recognized as a resource for biomarkers of cancer progression, treatment response, and drug resistance. However, few have demonstrated the usefulness of cfDNA for early detection of cancer. Although aberrant DNA methylation in cfDNA has...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res
Hlavní autoři: Uehiro, Natsue, Sato, Fumiaki, Pu, Fengling, Tanaka, Sunao, Kawashima, Masahiro, Kawaguchi, Kosuke, Sugimoto, Masahiro, Saji, Shigehira, Toi, Masakazu
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5168705/
https://ncbi.nlm.nih.gov/pubmed/27993161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0788-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky